AdipoRon Engages Microglia to Antinociception through the AdipoR1/AMPK Pathway in SNI Mice

Qian Fang1, Jie Li1, Yaping Wang2

  • 1Department of Rehabilitation, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282 Guangdong, China.

Abstract

Insights

AdipoRon alleviates neuropathic pain (NeuP) by reducing microglia-derived tumor necrosis factor-alpha (TNF-α) via the adiponectin receptor 1 (AdipoR1)/adenosine monophosphate-activated protein kinase (AMPK) pathway. This study demonstrates AdipoRon

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia-driven neuroinflammation is central to neuropathic pain (NeuP) development.
  • AdipoRon, an adiponectin analog, targets the AdipoR1/AMPK pathway for anti-inflammatory effects.
  • The AdipoR1/AMPK pathway regulates inflammatory responses.

Purpose of the Study:

  • To investigate AdipoRon's efficacy in alleviating NeuP.
  • To determine if AdipoRon inhibits microglia-derived tumor necrosis factor-alpha (TNF-α) via the AdipoR1/AMPK pathway.

Main Methods:

  • Established a NeuP mouse model using spared nerve injury (SNI).
  • Assessed mechanical allodynia using the von Frey test.
  • Utilized Western Blot, immunofluorescence, and qPCR to analyze molecular and cellular changes in vivo and in vitro (BV2 cells).

Main Results:

  • AdipoRon treatment reduced mechanical hypersensitivity in SNI mice.
  • AdipoRon decreased TNF-α expression and microglia activation in the spinal cord.
  • In vitro, AdipoRon inhibited inflammatory responses and modulated the AdipoR1/AMPK pathway in BV2 cells.

Conclusions:

  • AdipoRon effectively alleviates neuropathic pain.
  • The mechanism involves the inhibition of microglia-derived TNF-α through the AdipoR1/AMPK pathway.